We showed that FTY720, an FDA approved oral drug, could induce apoptosis of Kasumi-1 cells, an AML cell line possessing both t(8;21)(q22:q22) and c-kit mutations, in vitro and in Xenograft model. The gene discussed is KIT; the disease is acute myeloid leukemia.